HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs and procedure shows promise for liver cancer
Disease control OngoingThis study tests a mix of three drugs (durvalumab, bevacizumab, tremelimumab) plus a procedure called TACE (which delivers chemotherapy beads to the liver) in people with advanced liver or bile duct cancer. The goal is to see if this combination can stop the cancer from growing f…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New combo therapy targets advanced cancers in early trial
Disease control OngoingThis study tests a new drug called Q702 combined with pembrolizumab (an immunotherapy) in people with advanced esophageal, stomach, liver, or cervical cancer that has worsened after prior treatment. The goal is to see if the combination is safe and can shrink tumors. About 120 pa…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Cancer vaccine trial pulled before starting: hope for GI patients on hold
Disease control TerminatedThis study aimed to see if a person's own immune cells, modified in a lab to target specific cancer gene mutations, could prevent advanced gastrointestinal cancers from coming back after standard treatment. It was designed for people whose blood tests showed signs of remaining ca…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New blood test could spot liver cancer earlier than ultrasound
Diagnosis OngoingThis study looks at how well a new blood test, called Oncoguard™ Liver, finds liver cancer early in people who are at high risk (like those with cirrhosis or hepatitis B). About 3,000 adults will take part, and the test's results will be compared to standard ultrasound. The goal …
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 15, 2026 18:56 UTC
-
10,000 liver cancer patients enrolled in massive Real-World study
Knowledge-focused OngoingThis study follows 10,000 adults with hepatocellular carcinoma (a type of liver cancer) to see how the disease changes over time and how different treatments affect patients in real life. Researchers are collecting information from regular doctor visits and patient surveys, and b…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC